|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pressure -in- duced structureral phase transformation and elastic properties of transition metal mononitrides 显示文摘 | Poonam O Mahendra A Sankar P S | 2007 | Jour- nal of Physics and Chemistry of Solids2007，68，： | 1 |
| 2 | Advances in microbial amylases显示文摘 | Ashok P Poonam N Carlos R S | 2003 | Biochem2003，，31： | 1 |
| 3 | Advances in microbial amylases 显示文摘 | ASHOK P POONAM N CARLOS R | 2000 | Biotechnol Appl Biochem2000，31，： | 1 |
| 4 | Ownership effect in the Wild: Influence of Land Ownership on Agribusiness Goals and Decisions in the Argentine Pampas显示文摘 | Poonam A Federico B Guillermo P | 2015 | Journal of Behavioral and Experimental Economics2015，58，10： | 1 |
| 5 | Advances in microbial amylases显示文摘 | Ashok P Poonam N Carlos RS | | 0，，31： | 1 |
| 6 | Cyclo-oxygenase-2 expression and prostaglandin E2 production in experimental chronic gastric ulcer healing显示文摘 | Poonam D Vinay CS Gautam P | 2005 | Eur J Pharmacol2005，519，： | 1 |
| 7 | Laccase production by some Phlebia species显示文摘 | Arora D S Poonam P | 2002 | Journal of Basic Microbiol2002，42，5： | 1 |
| 8 | Impact of different abiotic stresses on growth, photosynthetic electron transport chain, nutrient uptake and enzyme activities of Cu-acclimated Anabaena doliolum显示文摘 | Thapar R Srivastava A K Poonam B P | 2008 | Journal of Plant Physiology2008，165，3： | 1 |
| 9 | Phase Ⅲ HIV vaccine trial in Thailand:a step toward a protective vaccine for HIV显示文摘 | Vaccari M Poonam P Franchini G | 2010 | Expert Rev Vaccines2010，9，9： | 1 |
| 10 | Improvement in physicochemical proper-ties of ezetimibe using a crystal engineering technique显示文摘 | SNEHAL P Mulye SAMINA A Jamadar POONAM SKarekar | 2012 | Powder Technol2012，222，2012： | 1 |
| 11 | Appraisal of GABAand PABA as linker: Design and synthesis of novelbenzamide based histone deacetylase inhibitors显示文摘 | Harish R Pramod K Poonam P | 2012 | Eur JMed Chem2012，53，： | 1 |
| 12 | Phase m HIV vaccine trim in Thailand: a step toward a protective vaccine for HIV 显示文摘 | Vaccari M Poonam P Franchini G | 2010 | Expert Rev Vaccines2010，9，9： | 1 |
| 13 | Ownership effect in the Wild: Influence of Land Ownership on Agribusiness Goals and Decisions in the Argentine Pampas显示文摘 | Poonam A Federico B Guillermo P | 2015 | Journal of Behavioral and Experimental Economics2015，58，10： | 1 |
| 14 | Advances in microbial amyla-ses显示文摘 | Ashok P Poonam N Carlos R | 2000 | Biotechnol Appl Biochem2000，31，： | 1 |
| 15 | Polymorphisms of MDR1, CYP2C19 and P2Y12 genes in Indian population: Effects on clopidogrel response 显示文摘 | KAVITA K S VINOD K S POONAM P | 2013 | India Heart J2013，65，14： | 1 |
| 16 | Solid-statefermentation for the production of industrial enzymes显示文摘 | PANDEY A SELVAKUMAR P POONAM N | 1999 | CurrentScience1999，77，1： | 1 |
| 17 | CFD investigation of the mixing of yield pseudoplastic fluids with anchor impellers显示文摘 | Poonam P Farhad E M | 2009 | Chem Eng Technol2009，32，8： | 1 |
| 18 | Bacterial decolorization and degradation of azo dyes显示文摘 | Anjali P Poonam S Leela I | 2007 | International Biodeterioration & Biodegradation2007，59，2： | 1 |
| 19 | CRS对比CRS+IP与CRS+HIPEC治疗上皮性卵巢癌辅助化疗时间及预后的前瞻性观察研究显示文摘目的:完全肿瘤细胞减灭术(cytoreductive surgery,CRS)及术后辅助化疗,是晚期原发性上皮性卵巢癌(epithelial ovarian cancer,EOC)的重要预后因素。然而,EOC患者接受辅助化疗开始时机及其与预后的关系尚不明确,值得深入探讨。方法:本研究选取2010年1月至2017年12月在印度班加罗尔马尼帕尔综合癌症中心接受完全细胞减灭术的185例晚期原发性EOC患者,其中部分患者接受腹腔化疗或辅助化疗,部分患者未接受腹腔化疗和辅助化疗。分别记录并分析术后开始进行辅助化疗的时间及其对预后的影响。结果:接受单纯CRS、CRS联合经腹腔港的腹腔内化疗(intraperitoneal chemotherapy,IP)或腹腔热灌注化疗(hyperthermic intraperitoneal chemotherapy,HIPEC)的患者分别为50例、60例和75例。CRS组术后开始接受辅助化疗的平均时间为32天,CRS+IP组为34天,CRS+HIPEC组为41天。CRS组中,术后化疗间隔时间>42天对无复发生存(relapse-free survival,RFS)期有显著影响(36个月vs. 17个月:P=0.02);在CRS+IP组中,患者RFS差异无统计学意义(35个月vs. 28个月;P=0.78);CRS+HIPEC组,RFS差异无统计学意义(35个月vs. 32个月;P=0.17)。如期行辅助化疗患者生存期较延迟化疗更好(88个月vs. 71个月,P=0.49)。结论:化疗时间延迟是单纯接受完全CRS患者RFS的不良预后因素。与非HIPEC组相比,化疗时间延迟对HIPEC组患者并未产生显著影响,其原因可能在于术中单次HIPEC弥补了化疗时间延迟带来的不利影响。 | Somashekhar SP Ramya Y Rohit Kumar C Shabber SZ Vijay A Amit R Poonam P Arun KN Ashwin KR 张凯(翻译) 李雁(审校) | 2022 | 中国肿瘤临床2022，49，24： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员